Â鶹ѧÉú¾«Æ·°æ

Maria A. Mendoza
No Rating Available
(Learn About Our Rating System)

Maria A. Mendoza, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Salt Lake City
801-585-2031

University of Utah Hospital

Infectious Diseases, Area E
Salt Lake City
801-585-2031

  • Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    Educational Commission for Foreign Medical Graduates

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Infectious Diseases
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    Educational Commission for Foreign Medical Graduates

    Education history

    Certification Postdoctoral Certificate Program in Clinical and Translational Science - Mayo Clinic Center for Clinical and Translational Science Certificate
    Fellowship Infectious Diseases – Immunocompromised/Transplant Track - Mayo Clinic College of Medicine & Science Fellow
    Residency Internal Medicine – Global Health/Tropical Medicine Track - University of Miami Leonard M. Miller School of Medicine, Jackson Memorial Hospital Resident
    Professional Medical Medicine - Universidad San Francisco de Quito School of Medicine M.D.
    Undergraduate Biology - Worcester Polytechnic Institute

    Selected Publications

    Journal Article

    1. Mendoza MA, Hass RM, Vaillant J, Johnson DR, Theel ES, Toledano M, Abu Saleh O (2023). Powassan virus encephalitis: a tertiary center experience. Clin Infect Dis. ()
    2. Chesdachai S, Yetmar ZA, Mendoza MA, Ranganath N, Schettle SD, Boilson BA, Shah AS, Razonable RR (2023). Clinical Characteristics and Outcomes of Clostridioides difficile Infection in Patients With Left Ventricular Assist Device. ASAIO J. ()
    3. Mendoza MA, Ranganath N, Chesdachai S, Yetmar ZA, Razonable R, Abu Saleh O (2023). Immunomodulators for severe coronavirus disease-2019 in transplant patients: Do they increase the risk of secondary infection? Transpl Infect Dis, 25(2), e14050. ()
    4. Mendoza MA, Motoa G, Raja MA, Frattaroli P, Fernandez A, Anjan S, Courel SC, Natori A, OBrien CB, Phancao A, Sinha N, Vianna R, Loebe M, Ciancio G, Simkins J, Abbo L, Guerra G, Natori Y (2022). Difference between SARS-CoV-2, seasonal coronavirus, influenza, and respiratory syncytial virus infection in solid organ transplant recipients. Transpl Infect Dis, 25(1), e13998. ()
    5. Yetmar ZA, Ranganath N, Mendoza MA, Razonable RR (2022). Clinical and microbiologic outcomes of central nervous system cryptococcosis: Re-examining the need for a 2-week cerebrospinal fluid analysis. Mycoses, 65(7), 733-740. ()
    6. Mendoza MA, Alshaer MH, Roldan G, Castro JG, Ashkin D, Peloquin CA, Boulanger CV (2022). Effect of Rifabutin in Dolutegravir Dosing: A Case Series. J Int Assoc Provid AIDS Care, 21, 23259582221111077. ()
    7. Camargo JF, Mendoza MA, Lin R, Moroz IV, Anderson AD, Morris MI, Natori Y, Natori A, Raja M, Lekakis L, Beitinjaneh A, Jimenez A, Goodman M, Wang T, Komanduri KV, Pereira D (2021). Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy. Transpl Infect Dis, 23(4), e13625. ()
    8. Memari M, Mendoza MA, Shukla B, ORourke P (2021). Things We Do for No Reasonâ„¢: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection. J Hosp Med. ()
    9. Mendoza MA, Iyer S, Camargo JF, Benedetto PW (2021). Pneumocystis jirovecii pneumonia as a complication of etoposide therapy. BMJ Case Rep, 14(6). ()
    10. Raja MA, Mendoza MA, Villavicencio A, Anjan S, Reynolds JM, Kittipibul V, Fernandez A, Guerra G, Camargo JF, Simkins J, Morris MI, Abbo LA, Natori Y (2020). COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature. Transplant Rev (Orlando), 35(1), 100588. ()
    11. Greissman S, Mattiazzi A, Mendoza M, Natori Y, Grady M, Quinonez J, Zukerman R, Camargo JF, Morris MI, Simkins J, Guerra G, Abbo LM (2020). Antimicrobial resistance and recurrent bacterial urinary tract infections in hospitalized patients following kidney transplantation: A single-center experience. Transpl Infect Dis, 22(4), e13337. ()
    12. Mendoza MA, Anderson A, Morris MI, Lekakis L, Simkins J, Prado CE, Martinez OV, Komanduri KV, Camargo JF (2020). Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient. Mycopathologia, 185(2), 399-403. ()
    13. Hernndez I, Barzallo J, Beltrn S, Castillo A, Cevallos N, Hernndez P, Lpez C, Vera R, Yerovi G, Mendoza A, Tern S, Izurieta A, Teran E (2019). Increased incidences of noninfectious comorbidities among aging populations living with human immunodeficiency virus in Ecuador: a multicenter retrospective analysis. HIV AIDS (Auckl), 11, 55-59. ()
    14. Konno H, Chinn IK, Hong D, Orange JS, Lupski JR, Mendoza A, Pedroza LA, Barber GN (2017). Pro-inflammation Associated with a Gain-of-Function Mutation (R284S) in the Innate Immune Sensor STING. Cell Rep, 23(4), 1112-1123. ()

    Review

    1. Mendoza MA, Razonable RR (2023). Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients. [Review]. Infect Dis Clin North Am, 37(3), 475-493. ()

    Letter

    1. Mendoza MA, Raja M, Villavicencio A, Anjan S, Natori Y (2020). Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population? [Letter to the editor]. Am J Transplant, 21(4), 1670-1671. ()